Previous Article | Next Article 
Journal of Virology, October 2000, p. 8854-8860, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Leader Sequences Downstream of the Primer Binding
Site Are Important for Efficient Replication of Simian
Immunodeficiency Virus
Yongjun
Guan,1
James B.
Whitney,1,2
Karidia
Diallo,1,2 and
Mark A.
Wainberg1,2,*
McGill University AIDS Centre, Lady Davis
Institute-Jewish General Hospital, Montreal, Quebec, Canada H3T
1E2,1 and Department of Microbiology and
Immunology, McGill University, Montreal, Quebec Canada H3A
2B42
Received 2 March 2000/Accepted 6 July 2000
 |
ABSTRACT |
Simian immunodeficiency virus (SIV) infection of macaques is
remarkably similar to that of human immunodeficiency virus type 1 (HIV-1) in humans, and the SIV-macaque system is a good model for AIDS
research. We have constructed an SIV proviral DNA clone that is deleted
of 97 nucleotides (nt), i.e., construct SD, at positions (+322 to +418)
immediately downstream of the primer binding site (PBS) of SIVmac239.
When this construct was transfected into COS-7 cells, the resultant
viral progeny were severely impaired with regard to their ability to
replicate in C8166 cells. Further deletion analysis showed that a virus
termed SD1, containing a deletion of 23 nt (+322 to +344), was able to
replicate with wild-type kinetics, while viruses containing deletions
of 21 nt (+398 to +418) (construct SD2) or 53 nt (+345 to +397)
(construct SD3) displayed diminished capacity in this regard. Both the
SD2 and SD3 viruses were also impaired with regard to ability to
package viral RNA, while SD1 viruses were not. The SD and SD3
constructs did not revert to increased replication ability in C8166
cells over 6 months in culture. In contrast, long-term passage of the SD2 mutated virus resulted in a restoration of replication capacity, due to the appearance of four separate point mutations. Two of these
substitutions were located in leader sequences of viral RNA within the
PBS and the dimerization initiation site (DIS), while the other two
were located within two distinct Gag proteins, i.e., CA and p6. The
biological relevance of three of these point mutations was confirmed by
site-directed mutagenesis studies that showed that SD2 viruses
containing each of these substitutions had regained a significant
degree of viral replication capacity. Thus, leader sequences downstream
of the PBS, especially the U5-leader stem and the DIS stem-loop, are
important for SIV replication and for packaging of the viral genome.
 |
INTRODUCTION |
Simian immunodeficiency virus (SIV)
and human immunodeficiency virus type 1 (HIV-1) belong to the primate
lentivirus subfamily of retroviruses. They both possess at least six
auxiliary genes and are considered complex retroviruses (7,
8). SIV can induce an AIDS-like disease in certain monkeys, such
as rhesus macaques, and is an excellent animal model for the study of
human HIV disease (15). The 5' untranslated leader sequences
of HIV possess a number of functional domains, including elements for transactivation of transcription, initiation of reverse transcription, packaging of viral RNA, and integration of the proviral genome (5,
6, 11, 12, 17, 31). A 54-nucleotide (nt) leader sequence in
HIV-1, located downstream of the primer binding site (PBS) and upstream
of the dimerization initiation site (DIS), has been shown to be
involved in efficient HIV-1 gene expression and virus replication
(16, 18, 20). SIVmac239 has 97-nt sequences in this region,
which is therefore much longer than that of HIV-1 (29). The
5' untranslated leader sequence of the SIV RNA genome has little
sequence similarity with that of HIV-1, but similar secondary
structures have been predicted (30). SIV also shows certain
unique features in the leader sequence, such as an intron located in
the 5' R-U5 region and an internal ribosome entry site found in the SIV
leader sequence but not in HIV-1 (26, 32). We conducted
studies to determine the role of the region located downstream of the
PBS and upstream of the DIS in SIV, an area that is not well understood.
Using mutational analysis, we show that SIV mutants containing a 97-nt
deletion of these leader sequences is severely impaired with regard to
both viral replication and packaging of viral RNA. A 23-nt sequence
within the 5' portion of this 97-nt region had only minor effects on
viral genomic RNA packaging and SIV replication in C8166 cells.
However, the remaining 74 nt within this region played a significant
role in viral genomic RNA packaging and replication in the
aforementioned cell line.
(Research performed by James B. Whitney was in partial fulfillment of
the Ph.D. degree, Faculty of Graduate Studies and Research, McGill
University, Montreal, Canada.)
 |
MATERIALS AND METHODS |
Construction of deletion mutations.
The two half-genome
plasmids of SIVmac239, molecular clones p239SpSp5' and p239SpE3', were
obtained through the AIDS Research and Reference Reagent Program
(28). Nucleotide designations for SIVmac 239 are based on
the published sequence; the transcription initiation site corresponds
to +1. Table 1 shows the primers used in
our experiments. To obtain the full-length clone, the 5' cellular
sequence was replaced with an EcoRI site, and the 3'
cellular sequence was replaced with a XhoI site by PCR-based methodology, using primers pSU3 and pSPBS and primers pSU5-1 and pSenf.
A full-length clone was constructed by inserting the ligation product
of the 5' EcoRI-SphI fragment and the 3'
SphI-XhoI fragment into the
EcoRI-XhoI site of a pSP73 vector. Deletion
mutants were then constructed based on this full-length infectious
clone, termed SIV-WT. We used PCR-based mutagenesis methods to generate
deletions downstream of the PBS. Pfu polymerase was used to
increase the reliability of the PCR. All constructs were confirmed by
sequencing. Figure 1 presents a graphic
description of the mutants generated in regard to both the sequence and
the tertiary structure. Briefly, the region between the NarI
and BamHI sites in SIV-WT was replaced by PCR fragments to
generate mutant constructs (primers pSD and pSgag1 were used for SD
deletion, and primers pSD1 and pSgag1 were used for SD1 deletion). For
construction of SD2 and SD3 deletion, PCR fragments (pSD2 and pSgag1
for SD2, pSD3 and pSgag1 for SD3) were purified and were then used as a
mega-primer paired with primer pSU5 to generate PCR fragments to
replace the region between NarI and BamHI sites
in SIV-WT.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 1.
Deletion mutations and RNA secondary structure. (A)
Deletions are located between the arrows, and their positions are shown
relative to the transcription initiation site. (B) Secondary structure
of SIVmac239 leader RNA model was predicted by free-energy minimization
(33, 34) and was adapted from published structures (1,
30). All hairpin motifs are named after their putative function
or after similar elements encoded by HIV-1. The following sequence
motifs are noted: the polyadenylation signal at position 153, the PBS
at position 303, the DIS palindrome at position 419, and the Gag start
codon at position 534. The splice donor and acceptor sites in the R-U5
region (positions 60 and 204) are marked by a dotted arrow, while the
major splice donor site at position 466 is marked by a solid arrow. The
positions of deletion constructs are shown above the structure.
|
|
Cells and preparation of virus stocks.
COS-7 cells were
maintained in Dulbecco modified Eagle medium supplemented with 10%
heat-inactivated fetal bovine serum. C8166 cells were maintained in
RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine
serum. All media and sera were from GIBCO (Burlington, Ontario,
Canada). Molecular constructs were purified using a Maxi Plasmid Kit
(Qiagen, Inc. Mississauga, Ontario, Canada). COS-7 cells were
transfected using these constructs with Lipofectamine-Plus reagent
(GIBCO). Virus containing supernatant was harvested at 60 h after
transfection and was clarified by centrifugation for 10 min at 4°C at
3,000 rpm in a Beckman GS-6R centrifuge. Viral stocks were stored in
0.5- or 1-ml aliquots at
70°C. The concentration of p27 antigen in
these stocks was quantified using a Coulter SIV core antigen assay kit
(Immunotech, Inc., Westbrook, Maine).
Virus replication in C8166 cells.
Viral stocks were thawed
and treated with 100 U of DNase I in the presence of 10 mM
MgCl2 at 37°C for 1 h to eliminate any residual
contaminating plasmids from the transfection. Infection of C8166 cells
was performed by incubating 106 cells at 37°C for 2 h with an amount of virus equivalent to 10 ng of p27 antigen. Infected
cells were then washed twice with phosphate-buffered saline and
incubated with fresh medium. Cells were split at a 1:3 ratio twice per
week if they had grown to a sufficient level; otherwise the culture
fluid was replaced with fresh medium. Supernatants were monitored for
virus production by both reverse transcriptase (RT) assay and SIV core
antigen capture assay (Immunotech).
Detection of viral DNA.
At various times postinfection,
C8166 cells were collected and washed with phosphate-buffered saline.
To ensure that no contaminating plasmid remained, fluid from the wash
was routinely checked by PCR using SIV-specific primers. Cellular DNA
was isolated using a QIAamp DNA Mini Kit (Qiagen). DNA samples were
analyzed by PCR using primers the pSPBS-1 and Sg to amplify the
deletion region between the PBS and the major splice donor site of SIV.
PCR assays were performed with 0.1 to 1 µg of sample DNA, 50 mM
Tris-HCl (pH 8.0), 50 mM KCl, 1.5 mM MgCl2, 2.5 U of Taq
polymerase, 0.2 mM concentrations of deoxynucleoside triphosphates
(dNTPs) 10 pmol of 32P-end-labeled reverse primer, and 20 pmol of unlabeled forward primer and then programmed as follows: 95°C
at 3 min and 25 cycles at 94°C for 30 s, 55°C for 30 s,
72°C for 1 min, and 72°C for 10 min. Reactions were standardized by
a simultaneous amplification of a 567-bp DNA fragment of human
-actin gene as an internal control. Products were separated through
5% native polyacrylamide gels. Products derived from PCR using
unlabeled primers were separated in agarose gels and extracted using a
Qiaex II Gel Extraction Kit (Qiagen). The purified DNA was used as
template to confirm deletion mutations via sequencing.
Detection of viral proteins produced by transfected COS-7
cells.
Expression of viral proteins by transfected COS-7 cells was
determined using a Coulter SIV core antigen assay and a Western blot.
For the Western blot, nascent extracellular virions were precipitated
by ultracentrifugation and used as protein samples. Western blotting
was performed using SIVmac 251 antiserum according to a standard
protocol (23).
Detection of RNA in virions by RT-PCR.
To study packaging of
viral genomic RNA, viral RNA was isolated using the QIAamp viral RNA
Mini Kit (Qiagen) from equivalent amounts of COS-7 cell-derived viral
preparations based on levels of SIV p27 antigen. RNA samples were
treated with RNase-free DNase I at 37°C for 30 min to eliminate
possible DNA contamination. DNase I was then inactivated by incubation
at 75°C for 10 min. The viral RNA samples were quantified by RT-PCR,
using the Titan One Tube RT-PCR system (Boehringer Mannheim, Montreal,
Quebec, Canada). The primer pairs sg1 and sg2 were used to amplify a
114-bp fragment representing full-length viral genome. The primer sg2 was radioactively labeled in order to visualize PCR products. Equivalent RNA samples, based on p27 antigen levels, were used as
templates in an 18-cycle RT-PCR. The products were fractionated on 5%
polyacrylamide gels and exposed to X-ray film. Relative amounts of
products were quantified by molecular imaging (Bio-Rad Imaging). Levels
of genomic packaging were calculated on the basis of four different
reactions, with wild-type virus levels arbitrarily set at 1.0.
Site-directed mutagenesis.
For the introduction of point
mutations into the SD2 genome, the fragment between the
BamHI and SphI sites was subcloned into the pSP73
vector to generate a clone termed pSIV-BSp, and the fragment between
the EcoRI and BamHI sites was subcloned into the
pSP73 vector to generate the clone termed pSIV-EB-SD2. The QuikChange
site-directed mutagensis kit (Stratagene, La Jolla, Calif.) was used to
introduce the M2, CA1, and Mp6 point mutations into SD2 DNA by
procedures that have been previously described (21) and
utilizing the following primer pairs, i.e., M2-1
(5'-CCAACCACGACGGAGTGGTGCCAGACGGCGTGAGG-3') and M2-2
(5'-CCTCACGCCGTCTGGCACCACTCCGTCGTGGTTGG-3') for M2, CA1-1 (5'-GCTAACCCAGATTGCAGGCTAGTGCTGAAGGG-3') and CA1-2
(5'-CCCTTCAGCACTAGCCTGCAATCTGGGTTAGC-3') for CA1, and Mp6-1
(5'-GCCTTACAAGGAGGTGACAAAGGATTTGCTGCACCTC-3') and Mp6-2
(5'-GAGGTGCAGCAAATCCTTTGTCACCTCCTTGTAAGGC-3') for Mp6. The
EcoRI-BamHI fragment was cloned back into the SD2
genome to generate the SD2-M2 clone; the
BamHI-SphI fragment was cloned into the SD2
genome to generate both the SD2-CA1 and SD2-Mp6 clones. To generate the
M1 mutation, the fragment which was produced by PCR using primers
PBS-M1 (5'-TGGCGCCCGAACAGGGACTTG-3') and pSgag1 (based on
the SD2 template, see above) was inserted into the SD2 genome between
the NarI and BamHI sites to yield the SD2-M1
clone. The presence of all point mutations was confirmed by direct sequencing.
 |
RESULTS |
Sequences downstream of the PBS are important for SIV replication
in C8166 cells.
To investigate the role of leader sequences
located downstream of the PBS in SIVmac239, we constructed deletion
mutations in this region (Fig. 1). First, a 97-nt (positions +322 to
+418) deletion was introduced into the region immediately downstream of
the PBS, i.e., construct SD; this construct abolished both the putative
U5-leader stem and the DIS stem-loop. Alternatively, three subdeletions
within this 97-nt region were generated, termed SD1 (+322 to +344), SD2
(+398 to +418), and SD3 (+345 to +397), respectively. SD1 retains a
stable U5-leader stem but is deleted of the small stem-loop within the
U5-leader stem. SD2 is deleted of the left side half of the DIS
stem-loop. Finally, SD3 retains the DIS stem-loop but is deleted of the
U5-leader stem (Fig. 1).
To investigate the replicative potential of these constructs, the viral
stock was thawed and treated with DNase I to eliminate
any possible
contaminating plasmids. Viruses containing 10 ng
of p27 antigen were
used to infect C8166 cells, and culture fluids
were monitored for virus
replication by RT assay and by SIV p27
antigen capture assay. Figure
2 shows that each of the SD, SD2,
and SD3
deletion mutants were significantly impaired in their
ability to
replicate in C8166 cells, while wild-type virus and
one of the deletion
mutants (SD1) replicated efficiently, as determined
by levels of RT
activity in culture fluids. The data in Table
2 also show that the SD1 construct
yielded levels of p27 antigen
similar to those of wild-type virus,
while the SD, SD2, and SD3
deletion constructs were severely impaired
in this regard.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Growth curves of mutated viruses in C8166 cells.
Equivalent amounts of virus from COS-7 transfected cells were used to
infect C8166 cells based on levels of p27 antigen (10 ng/106 cells). Viral replication was monitored by RT assay
of culture fluids. Mock infection denotes exposure of cells to
heat-inactivated wild-type virus as a negative control.
|
|
We also measured levels of proviral DNA in these studies by PCR. The
sequencing of PCR products indicated that the deletions
were retained,
even after replication over several passages (results
not shown).
Figure
3A shows the PCR results of
samples at 7 days
postinfection, confirming that these deleted viruses
were indeed
able to infect C8166 cells but that the levels of proviral
genomic
DNA with regard to the SD, SD2, and SD3 viruses were diminished
relative to the wild-type virus (Fig.
3B).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Detection of viral DNA. (A) Viruses derived from COS-7
cells were standardized on the basis of p27 and used to infect C8166
cells. Total cellular DNA was isolated from infected cells at 7 days
after infection and subjected to PCR analysis with primers pSPBS-1 and
sg, that specifically amplify an SIV cDNA fragment between the PBS and
a site downstream of the DIS. The size of the PCR products vary based
on the type of construct used and are 264 bp for wild-type virus (lane
1), 241 bp for the SD1 deletion virus (lane 2), 243 bp for the SD2
deletion virus (lane 3), 211 bp for the SD3 deletion virus (lane 4),
and 167 bp for the SD construct (lane 5). Primers amplifying a 587-bp
fragment of -actin were used as an internal control. Mock infection
was done by inoculation of cells with heat-inactivated viruses (lane
6). A DNA marker of a 100-bp ladder is also shown (lane 7). (B) The
intensity of each band was quantified by molecular imaging, and the
band intensity of viral DNA relative to cellular DNA for each sample is
shown.
|
|
The deletion mutations affect the packaging of viral genomic
RNA.
To investigate the potential mechanisms whereby virus
replication was compromised, we determined the levels of virus
production by transfected COS-7 cells. Levels of extracellular SIV p27
antigen were quantified using the SIV p27 antigen capture assay. The
results show that similar amounts of p27 were produced in each case
(Table 3). We next analyzed viral
proteins by Western blotting, and the results also show that no
significant differences were present with regard to viral protein
production (Fig. 4).

View larger version (125K):
[in this window]
[in a new window]
|
FIG. 4.
Western blot to detect viruses derived from COS-7 cells.
Viruses were pelleted by ultracentrifugation at 60 h after
transfection, and viral proteins were detected by using SIV-positive
serum. The band indicating the p27 protein is indicated by the arrow.
|
|
To determine the efficiency of packaging of the viral genome, RNA
samples were isolated from equivalent amounts of SIV virus,
based on
p27 levels. A 114-bp fragment that represents the full-length,
unspliced RNA genome was amplified and quantified by RT-PCR. The
results of Fig.
5 show that the SD1
deletion had no effect on
the encapsidation of viral RNA, while the SD,
SD2, and SD3 constructs
resulted in diminution of RNA packaging by
about six-, two-, and
threefold, respectively. Therefore, sequences in
each of SD2 and
SD3 are likely involved in the packaging of the viral
genome,
while those in SD1 are not.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Viral RNA packaging in wild-type and mutated viruses.
Viral RNA was purified from virus stock derived from transfected COS-7
cells. Equivalent amounts of virus based on levels of p27 antigen were
used as a template. Quantitative RT-PCR was performed to detect
full-length viral RNA genome in an 18-cycle PCR reaction. Relative
amounts of a 114-bp DNA product were quantified by molecular imaging,
with wild-type levels arbitrarily set at 1.0. Reactions run with RNA
template, digested by DNase-free RNase, served as a negative control
for each sample to exclude any potential DNA contamination. Relative
amounts of viral RNA that were packaged were determined on the basis of
four different experiments.
|
|
Long-term culture results in reversion of SD2 viruses.
To
investigate the possibility of reversion, we cultured the infected
cells over longer periods and did not find any sign of reversion of the
SD and SD3 constructs at over 6 months of passage. In contrast, modest
amounts of RT activity in cultures infected by the SD2 viruses were
present after 6 weeks. The supernatant fluids of the SD2 infection were
then used to infect new C8166 cells, and viral culture fluids at peak
levels of RT activity were again passaged onto new C8166 cells. After
four passages (18 weeks), viral replication capacity was now similar to
that of wild-type viruses (Fig. 6).
Proviral DNA of these reverted viruses was detected by PCR, and the
region from the 5' long terminal repeat to the end of the
gag gene was cloned. Six of these clones were sequenced, and
the results showed that the original deletion had been retained in each
case but that four additional point mutations were also present. These
four point mutations were located within the PBS (termed M1), the
putative DIS loop (termed M2), the capsid protein (termed CA1), and the
p6 protein (termed Mp6) of the gag gene (Fig.
7). Each of these mutations is novel with the exception of M1, which has been observed in sequences of some wild-type viruses. The CA1 mutation involved a change of Lys-197 to
Arg, while the Mp6 substitution results in a change from Glu-49 to Lys.
Neither the M1 nor the M2 mutations involve amino acid substitutions,
since both are located in noncoding areas of the viral genome. The M1
mutation (thymidine [T] to cytidine [C] at position 310) resulted
in an alteration of the PBS, such that complementarity now existed with
the 3' end of tRNA3Lys instead of the original
tRNA5Lys (31). The M2 substitution involved
a change from adenosine (A) to guanosine (G) at position 423, which is
located in the loop of the putative DIS stem-loop structure. RNA
secondary structure analysis suggests that this point mutation cannot
restore the destroyed DIS stem-loop structure in SD2 (data not shown).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 6.
Reversion of the SD2 mutant after long term culture in
C8166 cells. (A) Growth curves of viruses in long-term culture.
Equivalent amounts of virus from COS-7 transfected cells were used to
infect C8166 cells based on levels of p27 antigen (10 ng/106 cells). Infected cells were cultured over protracted
periods, and culture fluids were monitored by RT assay. Mock infection
denotes exposure of cells to heat-inactivated wild-type virus as a
negative control. (B) Growth curves of reverted SD2 viruses in C8166
cells. The SD2 virus at 42 days after the initial infection was
passaged in fresh C8166 cells. Growth curves of the first and fourth
passages of the SD2 viruses are shown.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7.
Locations of the point mutations M1, M2, CA1, and Mp6
within the SIV genome, as indicated by asterisks. The substitutions
observed are as follows: M1, T-+310 to C within the PBS; M2, A-+423 to
G within the loop of the DIS; CA1, Lys-197 to Arg within CA; and Mp6,
Glu-49 to Lys within p6. Letters in boldface indicate the original
bases and amino acids, as well as the mutations. The PBS and the
putative DIS are also indicated. Sequences that were deleted in SD2 are
underlined.
|
|
In order to pursue the biological relevance of these various
substitutions. we performed site-directed mutagenesis to introduce
each
of these four point mutations into the SD2 genome. The resultant
DNA
clones termed SD2-M1, SD2-M2, SD2-CA1, and SD2-Mp6 were then
transfected into COS-7 cells, and the virus particles thereby
recovered
were assayed for viral replication capacity in C8166
cells. The results
(Fig.
8) show that each of the constructs
tested,
except for SD2-M1, was able to replicate more efficiently than
SD2 in the C8166 cell line, although not as efficiently as the
wild-type virus. Thus, each of the M2, CA1, and Mp6 point mutations
was
able to partially compensate for the SD2 deletion, whereas
the M1
substitution could not.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 8.
Growth curves of reverted viruses in C8166 cells.
Equivalent amounts of virus from COS-7 transfected cells were used to
infect C8166 cells based on levels of p27 antigen (10 ng/106 cells). Viral replication was monitored by RT assay
of culture fluids. Mock infection denotes exposure of cells to
heat-inactivated wild-type virus as a negative control.
|
|
 |
DISCUSSION |
Previous work has shown that leader sequences downstream of the
PBS are important for HIV-1 gene expression and replication, but little
about this subject is known with regard to SIV. In the present work, we
have investigated this subject by constructing a series of mutated SIV
clones containing deletions within a 97-nt region immediate downstream
of the PBS. The results show that mutants containing deletions in the
entire 97-nt region, as well as two subregions, were significantly
impaired with respect to replication capacity in C8166 cells. A
potential mechanism that may affect viral replication capacity in this
context is that these sequences appear to be important for the
packaging of the viral RNA genome. These results imply that both the
U5-leader stem and the DIS stem-loop structures are important for SIV
replication and for packaging of viral genomic RNA.
Packaging determinants have not been completely described for any
lentivirus, but interactions of multiple regions that are distributed
widely within the HIV-1 genome have been proposed (3). The
encapsidation of the HIV-1 viral genome is dependent on
cis-acting RNA elements located around the major splice
donor site, and the core-packaging signal is composed of a series of stem-loops (2, 10). It was originally thought that RNA
sequences downstream of the major splice donor site were responsible
for the specific packaging of viral genomic RNA in a manner that would exclude the packaging of spliced viral RNA species in the case of
HIV-1. However, it has been reported that sequences upstream of the
splice donor are also important for efficient packaging of HIV-1 viral
genomic RNA (1, 4, 21, 24, 28). Similar results for HIV-2
have also been reported, but it was suggested that sequences upstream
of the major splice donor site were more important than those
downstream for efficient encapsidation of HIV-2 RNA. Therefore, HIV-2
may use different mechanisms to select unspliced RNA for encapsidation
(13, 14, 25, 28).
With regard to SIV RNA packaging determinants, only one study has
reported that leader sequences upstream of the major splice donor site
can be packaged into HIV-1 particles (30). Our results now
show that sequences located downstream of the PBS and upstream of the
major splice donor site, nt +345 to +418, are necessary for the
efficient encapsidation of SIV genomic RNA, since deletions within this
region have a detrimental effect on RNA packaging. This region includes
half of the putative DIS and half of the putative U5-leader stem
(1, 30). Therefore, these proposed structures likely serve a
functional role in the encapsidation process. The fact that genomes
with deletions of this entire region can still be packaged to some
extent indicates that sequences in disparate regions may also play a
role in the encapsidation of SIV genomic RNA.
Deletions in this region that result in impaired replication may not
only affect RNA packaging. Comparable work with HIV-1 has indicated
that sequences in this region also affect HIV-1 gene expression and may
affect Gag polyprotein processing (16, 18-21). Although our
results show that these deletions do not have any significant effect on
SIV protein expression in transfected COS-7 cells, further work is
required to characterize whether these deletions can affect proviral
DNA synthesis and gene expression in permissive cell lines.
Reversions of deleted mutated viruses have also been observed in
similar studies on HIV-1, and point mutations within four distinct Gag
proteins were shown to contribute to the increased replication capacity
of these viruses (22). Our results reveal that two of our
SIV constructs, i.e., SD and SD3, did not revert to increased
replication ability in C8166 cells over 6 months in culture. In
contrast, long-term passage of the SD2 mutated virus in these cells did
result in a restoration of replication capacity, due to the appearance
of four point mutations: M1, M2, CA1, and Mp6. Interestingly, two of
these mutations were located in leader sequences that flank the
deletion site, i.e., M1 and M2, and only two of these mutations were
located in Gag proteins, i.e., CA1 and Mp6. The M1 mutation was located
within the PBS 87 nt upstream of the SD2 deletion, while the M2
substitution was identified in the loop of the DIS only 3 nt downstream
of the SD2 deletion. These findings imply that there may be important differences between SIV and HIV-1 with regard to mechanism(s) of RNA
packaging and in regard to the interactions between Gag proteins and
leader sequences.
Site-directed mutagenesis studies have confirmed the biological
relevance of each of these substitutions with the exception of M1.
Since the M1 mutation has also been observed in infections with both
wild-type and SD1 virus (data not shown), this substitution does not
appear to be novel; rather, it may be a natural polymorphism involved
in the binding of tRNA3Lys, which is used more
efficiently by SIV than tRNA5Lys in human cells as a
primer of reverse transcription (9). The M2 mutation was
best able to rescue the SD2 deletion, but could not restore the
putative DIS stem-loop structure. This implies that functions other
than dimer formation may account for the partially restored replication
capacity of SD2-M2 virus in C8166 cells. Further work is needed to
determine how these point mutations are individually involved in the
restoration of viral replication of the SD2 deletion virus; such
studies are in progress and also involve analyses of the M2, CA1, and
Mp6 mutations in various combinations. While M2 alone was not capable
of restoring the DIS stem-loop, it remains possible that a combination
of M2 with other mutations not yet discovered could do this, while
simultaneously enabling viral replication to resume with wild-type kinetics.
 |
ACKNOWLEDGMENTS |
The following reagents were obtained through the AIDS Research
and Reference Reagent Program, Division of AIDS, National Institute of
Allergy and Infectious Diseases, National Institutes of Health: SIVmac 251 antiserum, plasmids of p239SpSp5' and p239SpE3'. We thank Chen Liang for helpful advice and Mervi Detorio and Maureen Oliveira for expert technical assistance.
This research was supported by grant R01 AI43878-01 from the National
Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: McGill AIDS
Centre, Lady Davis Institute-Jewish General Hospital, 3755 Cote
Ste-Catherine Rd., Montreal, Québec, Canada H3T 1E2. Phone: (514)
340-8260. Fax: (514) 340-7537. E-mail:
mwainb1{at}po-box.mcgill.ca.
 |
REFERENCES |
| 1.
|
Berkhout, B., and J. L. B. van Wamel.
1996.
Role of the DIS hairpin in replication of human immunodeficiency virus type 1.
J. Virol.
70:6723-6732[Abstract/Free Full Text].
|
| 2.
|
Berkowitz, R. D.,
J. Fisher, and S. P. Goff.
1996.
RNA packaging.
Curr. Top. Microbiol. Immunol.
214:177-218[Medline].
|
| 3.
|
Berkowitz, R. D.,
M. L. Hammarskjold,
C. Helga-Maria,
D. Rekosh, and S. P. Goff.
1995.
5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal.
Virology
212:718-723[CrossRef][Medline].
|
| 4.
|
Clevel, J. L.,
D. A. Eckstein, and T. G. Parslow.
1999.
Genetic dissociation of the encapsidation and reverse transcription functions in the 5'R region of human immunodeficiency virus type 1.
J. Virol.
73:101-109[Abstract/Free Full Text].
|
| 5.
|
Cobrinik, D.,
A. Aiyar,
Z. Ge,
M. Katzman,
H. Huang, and J. Leis.
1991.
Overlapping U5 sequence elements are required for efficient integration and initiation of reverse transcription.
J. Virol.
62:3622-3630.
|
| 6.
|
Cobrinik, D.,
L. Soskey, and J. Leis.
1988.
A retroviral RNA secondary structure required for efficient initiation of reverse transcription.
J. Virol.
62:3622-3630[Abstract/Free Full Text].
|
| 7.
|
Cullen, B. R.
1991.
Human immunodeficiency virus as a prototypic complex retrovirus.
J. Virol.
65:1053-1056[Free Full Text].
|
| 8.
|
Cullen, B. R.
1992.
Mechanism of action of regulatory proteins of the primate immunodeficiency viruses.
Microbiol. Rev.
56:375-394[Abstract/Free Full Text].
|
| 9.
|
Das, A. T.,
B. Klaver, and B. Berkhout.
1997.
Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA Lys molecular in reverse transcription.
J. Gen. Virol.
78:837-840[Abstract].
|
| 10.
|
Harrison, G. P.,
G. Miele,
E. Hunter, and A. M. L. Lever.
1998.
Functional analysis of the core HIV-1 packaging signal in a permissive cell line.
J. Virol.
72:5886-5896[Abstract/Free Full Text].
|
| 11.
|
Hu, W. S., and H. M. Temin.
1990.
Retroviral recombination and reverse transcription.
Science
250:1227-1233[Abstract/Free Full Text].
|
| 12.
|
Kao, S. Y.,
A. F. Calman,
P. A. Luciew, and B. M. Peterlin.
1987.
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
Nature
330:33-38[CrossRef][Medline].
|
| 13.
|
Kaye, J. F., and A. M. L. Lever.
1999.
Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic ENA for encapsidation.
J. Virol.
73:3023-3031[Abstract/Free Full Text].
|
| 14.
|
Kaye, J. F., and A. M. L. Lever.
1998.
Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.
J. Virol.
72:5877-5885[Abstract/Free Full Text].
|
| 15.
|
Kestler, H.,
T. Kodama,
D. Ringler,
P. Sehgal,
M. D. Daniel,
N. King, and R. Desrosiers.
1990.
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
Science
248:1109-1112[Abstract/Free Full Text].
|
| 16.
|
Lenz, C.,
A. Scheid, and H. Schaal.
1997.
Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression.
J. Virol.
71:2757-2764[Abstract].
|
| 17.
|
Lever, A. M. L.,
H. Gottlinger,
W. Haseltine, and J. Sodroski.
1989.
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.
J. Virol.
63:4085-4087[Abstract/Free Full Text].
|
| 18.
|
Li, X.,
C. Liang,
Y. Quan,
R. Chandok,
M. Laughrea,
M. A. Parniiak,
L. Kleiman, and M. A. Wainberg.
1997.
Identification of sequences downstream of the primer-binding site that is important for efficient replication of human immunodeficiency virus type 1.
J. Virol.
71:6003-6010[Abstract].
|
| 19.
|
Liang, C.,
X. Li,
Y. Quan,
M. Langhrea,
L. Kleiman,
J. Hiscott, and M. A. Wainberg.
1997.
Sequence elements downstream of human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
J. Mol. Biol.
272:167-177[CrossRef][Medline].
|
| 20.
|
Liang, C.,
L. Rong,
E. Cherry,
L. Kleiman,
M. Laughrea, and M. A. Wainberg.
1999.
Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.
J. Virol.
73:6147-6151[Abstract/Free Full Text].
|
| 21.
|
Liang, C.,
L. Rong,
M. Laughrea,
L. Kleiman, and M. A. Wainberg.
1998.
Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.
J. Virol.
72:6629-6636[Abstract/Free Full Text].
|
| 22.
|
Liang, C.,
L. Rong,
Y. Quan,
M. Laughrea,
L. Kleiman, and M. A. Wainberg.
1999.
Mutations within four distinct Gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.
J. Virol.
73:7014-7020[Abstract/Free Full Text].
|
| 23.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 24.
|
McBride, M. S., and A. T. Panganiban.
1997.
Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo.
J. Virol.
71:2050-2058[Abstract].
|
| 25.
|
McCann, E. M., and A. M. L. Lever.
1997.
Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2.
J. Virol.
71:4133-4137[Abstract].
|
| 26.
|
Ohlmann, T.,
M. Lopez-Lastra, and J. L. Darlix.
2000.
An internal ribosome entry segment promotes translation of the simian immunodeficiency virus genomic RNA.
J. Biol. Chem.
275:11899-11906[Abstract/Free Full Text].
|
| 27.
|
Pailllart, J.-C.,
L. Berthoux,
M. Ottmann,
J.-L. Darlix,
R. Marquet,
B. Ehresmann, and C. Ehresmann.
1996.
A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis.
J. Virol.
70:8348-8354[Abstract].
|
| 28.
|
Poeschla, E.,
J. Gilbert,
X. Li,
S. Huang,
A. Ho, and F. Wong-Staal.
1998.
Identification of human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2 based lentivirus vectors.
J. Virol.
72:6527-6536[Abstract/Free Full Text].
|
| 29.
|
Regier, D. A., and R. C. Desrosiers.
1990.
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
AIDS Res. Hum. Retrovir.
6:1221-1231[Medline].
|
| 30.
|
Rizvi, T. A., and A. T. Panganiban.
1993.
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.
J. Virol.
67:2681-2688[Abstract/Free Full Text].
|
| 31.
|
Steffy, K., and F. Wong-Staal.
1991.
Genetic regulation of human immunodeficiency virus.
Microbiol. Rev.
55:173-205.
|
| 32.
|
Viglianti, G. A.,
E. P. Rubinstein, and K. L. Graves.
1992.
Role of the TAR RNA splicing in translational regulation of simian immunodeficiency virus from rhesus macaques.
J. Virol.
66:4824-4833[Abstract/Free Full Text].
|
| 33.
|
Zuker, M.
1989.
On finding all suboptimal foldings of an RNA molecule.
Science
244:48-52[Abstract/Free Full Text].
|
| 34.
|
Zuker, M.,
D. H. Mathews, and D. H. Turner.
1999.
Algorithms and thermodynamics for RNA secondary structure prediction: a practical guide in RNA biochemistry and biotechnology, p. 11-43.
In
J. Barciszewski, and B. F. C. Clark (ed.), NATO ASI series. Kluwer Academic Publishers, Dordrecht, The Netherlands.
|
Journal of Virology, October 2000, p. 8854-8860, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Das, A. T., Klaver, B., Harwig, A., Vink, M., Ooms, M., Centlivre, M., Berkhout, B.
(2007). Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Nontranscriptional Function of Tat in Viral Replication. J. Virol.
81: 11159-11169
[Abstract]
[Full Text]
-
Lanchy, J.-M., Lodmell, J. S.
(2007). An Extended Stem-Loop 1 Is Necessary for Human Immunodeficiency Virus Type 2 Replication and Affects Genomic RNA Encapsidation. J. Virol.
81: 3285-3292
[Abstract]
[Full Text]
-
Groot, F., Sanders, R. W., ter Brake, O., Nazmi, K., Veerman, E. C. I., Bolscher, J. G. M., Berkhout, B.
(2006). Histatin 5-derived Peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry.. J. Virol.
80: 9236-9243
[Abstract]
[Full Text]
-
Strappe, P. M., Greatorex, J., Thomas, J., Biswas, P., McCann, E., Lever, A. M. L.
(2003). The packaging signal of simian immunodeficiency virus is upstream of the major splice donor at a distance from the RNA cap site similar to that of human immunodeficiency virus types 1 and 2. J. Gen. Virol.
84: 2423-2430
[Abstract]
[Full Text]
-
Patel, J., Wang, S.-W., Izmailova, E., Aldovini, A.
(2003). The Simian Immunodeficiency Virus 5' Untranslated Leader Sequence Plays a Role in Intracellular Viral Protein Accumulation and in RNA Packaging. J. Virol.
77: 6284-6292
[Abstract]
[Full Text]
-
Whitney, J. B., Oliveira, M., Detorio, M., Guan, Y., Wainberg, M. A.
(2002). The M184V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus. J. Virol.
76: 8958-8962
[Abstract]
[Full Text]
-
Guan, Y., Diallo, K., Detorio, M., Whitney, J. B., Liang, C., Wainberg, M. A.
(2001). Partial Restoration of Replication of Simian Immunodeficiency Virus by Point Mutations in either the Dimerization Initiation Site (DIS) or Gag Region after Deletion Mutagenesis within the DIS. J. Virol.
75: 11920-11923
[Abstract]
[Full Text]
-
Guan, Y., Diallo, K., Whitney, J. B., Liang, C., Wainberg, M. A.
(2001). An Intact U5-Leader Stem Is Important for Efficient Replication of Simian Immunodeficiency Virus. J. Virol.
75: 11924-11929
[Abstract]
[Full Text]
-
Guan, Y., Whitney, J. B., Detorio, M., Wainberg, M. A.
(2001). Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted. J. Virol.
75: 4056-4067
[Abstract]
[Full Text]
-
Guan, Y., Whitney, J. B., Liang, C., Wainberg, M. A.
(2001). Novel, Live Attenuated Simian Immunodeficiency Virus Constructs Containing Major Deletions in Leader RNA Sequences. J. Virol.
75: 2776-2785
[Abstract]
[Full Text]
-
Smith, S. M., Khoroshev, M., Marx, P. A., Orenstein, J., Jeang, K.-T.
(2001). Constitutively Dead, Conditionally Live HIV-1 Genomes. EX VIVO IMPLICATIONS FOR A LIVE VIRUS VACCINE. J. Biol. Chem.
276: 32184-32190
[Abstract]
[Full Text]